What does Selank do? Benefits and evidence
A Russian nasal anxiety peptide with uncertain long-term benefit and safety.
Also called: Селанк, TP-7, Tuftsin-PGP, TKPRPGP.
Nootropic peptides · Tuftsin-derived peptide studied for anxiety and cognition.
Selank is a synthetic peptide used as a nasal anxiety medicine in Russia. Most small studies lacked placebo comparisons; lasting benefit and safety remain unclear. Some reports may reuse participants. Injected use has not been established.
- In Russia, its nose drops are given to people for anxiety and stress-related symptoms; this is not an approved use in the US. (Studied in a trial)
- In a small trial against a sedative anxiety drug, it caused less drowsiness, though anxiety scores fell a bit less. (Studied in a trial)
- In a small study (15 vs 15 people) of adjustment problems, those taking it had lower symptom scores at day 28. (Studied in a trial)
- People report calm focus and better productivity, often alongside Semax, though some notice no effect. (Reported by users)
Uses in the sources
- Studied for generalized anxiety, neurasthenia and other anxiety disorders. Evidence is short-term and mostly from Russia. (Studied in a trial) (source)
- Russian nasal instructions include anxiety, stress-related symptoms and adjustment problems. (Clinician-published) (source)
- People report calm focus, better productivity or no effect, often with Semax. (Reported by users) (source)
Related to Selank
- Semax: A Russian nasal peptide with limited human evidence for brain and nerve effects.
- PE-22-28: An experimental mood peptide studied in mice, with no human trials found.
- Dihexa: An experimental memory compound with disputed animal research and no established human dose.
- P21: An experimental memory peptide with animal research and no established human dose or safety profile.
- Cerebrolysin: An injectable pig brain mixture with mixed stroke, brain-injury and dementia evidence.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- The Prohibited List, World Anti-Doping Agency · World Anti-Doping Agency · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Australian Register of Therapeutic Goods (ARTG), Therapeutic Goods Administration · TGA
- Search, European Medicines Agency
- Semax-Related Bulk Drug Substances: Semax (Free Base) and Semax Acetate
- Symptoms of a stroke
- Селанк® | ЛП-№(010951)-(РГ-RU) | ГРЛС 2026
- POST-COVID SYNDROME, POSSIBILITIES FOR THERAPY OF ASTHENIC DISORDERS WITH SELANK, 2024
- Functional Connectomic Approach to Studying Selank and Semax Effects., Panikratova YR et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.